Next Article in Journal
Examining Public Messaging on Influenza Vaccine over Social Media: Unsupervised Deep Learning of 235,261 Twitter Posts from 2017 to 2023
Previous Article in Journal
Correlates of COVID-19 Vaccine Acceptance and Hesitancy in Rural Communities in Western Kenya
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluating Knowledge, Attitudes, and Behaviors toward HPV Infection and Vaccination among University Students in Italy

by
Gabriella Di Giuseppe
1,
Silvia Angelillo
2,
Aida Bianco
2,
Francesca Gallè
3,
Francesca Licata
2,
Giorgio Liguori
3,
Francesco Napolitano
1,
Carmelo Giuseppe Angelo Nobile
4,
Maria Pavia
1,
Concetta Paola Pelullo
3 and
Italo Francesco Angelillo
1,*
1
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
2
Department of Health Sciences, University of Catanzaro “Magna Graecia”, 88100 Catanzaro, Italy
3
Department of Movement Sciences and Wellbeing, University of Naples “Parthenope”, 80133 Naples, Italy
4
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata of Rende, 87036 Cosenza, Italy
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(10), 1517; https://doi.org/10.3390/vaccines11101517
Submission received: 28 July 2023 / Revised: 18 September 2023 / Accepted: 21 September 2023 / Published: 24 September 2023

Abstract

:
Background: This survey investigated the knowledge, attitudes, and behaviors towards HPV preventive measures among university students in Italy and their associated factors. Methods: The cross-sectional survey was conducted between November 2022 and April 2023. Results: Only 41.7% knew about HPV infection and the main preventive measures. Multilevel mixed-effects logistic regression analysis showed that females, those aged 25–30 years, those who have had oral sex, those who had received information about HPV infection and preventive measures from physicians, and those who needed additional information about HPV infection and preventive measures were more knowledgeable. Only 39.1% have received at least one HPV vaccination dose, whereas 29.2% and 31.7% had not been vaccinated or did not remember. Multilevel mixed-effects logistic regression analysis identified that female students enrolled in the field of health sciences, those who did not report a prior history of a sexually transmitted infection, and those with a higher knowledge about HPV infection and preventive measures were more willing to receive the HPV vaccination. Conclusions: Despite some limitations, this was the first detailed survey on this topic conducted in the post-acute phase of COVID-19 among university students in Italy. The survey underlined the need to develop and to implement comprehensive educational programs and health interventions among students, to enhance their knowledge and modify their attitudes and improve the HPV vaccine uptake.

1. Introduction

Human Papillomavirus (HPV) vaccines are the most effective method, along with other precautionary measures, to reduce the incidence of infections and prevent the associated cervical, vulvar, vaginal, oropharyngeal, anal, and penile cancers [1]. In Italy, the HPV vaccine is recommended and offered free of charge to adolescent males at 12 years and to females aged 12–25 years under the National Immunization Program [2]. Despite these recommendations, the vaccination coverage still lags behind the target of 95%, with only 32.2% and 26.7% female and male adolescents at 12 years having completed the vaccine series in 2021 [3].
In line with the initiation of the vaccination against HPV, a body of literature has focused attention on the level of knowledge, attitudes, and behaviors regarding preventive measures and the vaccination. When looking at this literature, many of the studies have been conducted among adolescents [4,5], parents [6,7,8], general population [9,10,11], and health care professionals [12,13,14]. During the COVID-19 pandemic, a worldwide decline in HPV and other vaccination coverage has been observed [15,16,17]. This is a major worry. However, it may be expected that the concern about the pandemic may be a positive key determinant for self-protection and intention towards HPV or other vaccinations. However, a limited number of studies have been conducted recently regarding HPV among university students. It is pivotal to address this knowledge gap since they are expected to be a sexually active population and, therefore, at higher risk of exposure to HPV. It is particularly important to conduct these surveys for the development and implementation of public health education campaigns in a way that is suitable for many individuals to either participate in a healthy lifestyle behavior, or to increase the vaccination uptake. Thus, this is the first survey of its kind in the post-acute phase of COVID-19 and the purposes were to investigate the level of knowledge of HPV infection and of the main preventive measures, the attitudes regarding the risk of acquiring an HPV infection, the behavior towards HPV preventive measures, and the willingness to receive HPV vaccination among university students in Italy and to understand the various associated factors.

2. Materials and Methods

2.1. Study Design, Participants, and Sampling Procedures

This survey is part of larger research activities that investigated the genotype-specific prevalence of HPV infection in southern Italy’s young population in urine and oral samples. A cross-sectional survey was conducted between November 2022 and April 2023. The target population consisted of students enrolled in a degree program in the fields of medicine, healthcare professions, pharmacy, and sports science from three public universities in various geographic locations of the southern part of Italy. In particular, the sample was selected with a two-stage cluster method. In the first stage, 25 degree courses have been selected from the lists of the three universities and in the second stage, from each course the students have been selected through a simple random sampling. The sample size of the survey was determined to be 768, assuming an expected genital HPV prevalence of 20% in the non-vaccinated population and a post-vaccination HPV 16/18 prevalence of 10%, with 95% confidence intervals and a 0.05 margin of error, and a design effect of 2. In addition, accounting for an expected response rate of 90%, the minimum number was increased to 853. Overall, a total of 1652 students were selected.

2.2. Data Collection and Questionnaire Design

The members of the research team approached the students on randomly selected days during their courses. A self-administered questionnaire was used for data collection. It required approximately 15 min to answer all the questions. At the beginning of the questionnaire, the students were informed of the main objectives of the survey, assured that it was completely anonymous, that the participation was voluntary, that the responses would be treated with complete confidentiality, that they could withdraw at any time during questionnaire completion without consequences, that they would not receive any financial compensation, that the data would be used for the objectives of the survey, and that the informed consent for their participation was implied by returning the questionnaire.
Six pieces of information were collected in the questionnaire. In the first part, all participants completed questions exploring socio-demographic and general characteristics including gender, age, and family history of cancer. In the second part, ten items assessed the level of knowledge about HPV. Five of these questions were closed-ended with “Yes”, “No”, and “Do not know” answers and the other five were multiple-choice types and participants were allowed to choose more than one answer from a list of the options offered. In the third part, concerns about the perception of the risk of acquiring an HPV infection or a related disease, or a sexually transmitted disease, were assessed with three items and for these questions the responses were measured on a five-point Likert scale with 1 being “strongly disagree/not at all” and 5 being “strongly agree/very much”. Three questions about preventive measures were asked including the perceived utility of the vaccination, of the Pap test, and of the DNA HPV test. In the fourth part, participants indicated whether they had been vaccinated against HPV and those who were unvaccinated responded to a question exploring their willingness or uncertainty or unwillingness to take it, and also to indicate the most likely reason(s) for their willingness or uncertainty or unwillingness from five options. The last part included questions on the main sources of HPV-infection and related preventive measures information and participants were requested to tick any of the five options offered. Finally, they were asked whether additional information was needed.
Before the questionnaire was distributed, a pilot study was conducted among a small group of 50 students in the field of health sciences to ensure the questionnaire was easy to understand and to answer.

2.3. Statistical Analysis

STATA software version 17 was used for the statistical analysis. First, the different information was presented as mean and standard deviation for the continuous variables and frequency and proportion for the categorical variables. Second, univariate analysis using the Chi-square test or Student’s t-test was performed to assess the associations, respectively, between categorical and continuous variables and the outcomes of interest. Third, independent variables with a p-value ≤ 0.25 in the univariate analysis were included in three multilevel mixed-effects logistic regression models to calculate the odds ratio (OR) and the 95% confidence interval (CI) in order to verify the significant relationship between dependent variables and independent variables. With the aim of accounting for the multilevel dataset structure (procedures are “nested” within degree courses), the variable degree courses were introduced in the models as a random factor. The outcomes of interest were the following: knowledge about the HPV infection and the preventive measures (score 0–4 = 0; score 5–10 = 1) (Model 1); quite/very concerned about the risk of acquiring an HPV infection (not at all/slightly/neutral = 0; quite/very = 1) (Model 2); and willingness to receive the HPV vaccination (no = 0; yes = 1) (Model 3). The outcome of Model 1 assessed the level of knowledge about HPV with the ten questions and it was created by giving the respondent a score of “1” for each correct answer and “0” for each incorrect or unknown answer. The total knowledge score for each respondent was calculated and ranged from 0 to 10; those with a score above the median value of 4 was considered to be knowledgeable, and coded with “1”, and those with a score below or equal to 4 to be unknowledgeable, and coded with “0”. The following independent variables have been tested for all outcomes: gender (male = 0; female = 1), age (18–24 = 0; 25–30 = 1), undergraduate health sciences course (no = 0; yes = 1), sexual orientation (asexual/bisexual/gay/lesbian/pansexual = 0; heterosexual = 1), family history of HPV-related cancers (no = 1; yes = 2; other = 3), having smoked at least 100 cigarettes during lifetime (no = 0; yes = 1), consuming alcohol (no = 0; yes = 1), having had sexual intercourse during lifetime (no = 0; yes = 1), current partners (none = 1; casual = 2; regular = 3), having had oral sex during lifetime (no = 0; yes = 1), having had a diagnosis of a sexually transmitted infection (STI) (no = 0; yes = 1), physicians as source of information about HPV infection and preventive measures (no = 0; yes = 1), and needing additional information about HPV infection and prevention (no = 0; yes = 1). The variable HPV vaccination status (no = 0; yes = 1; unknown = 2) was included in Models 1 and 2 and knowledge of HPV infection and preventive measures (score 0–4 = 0; score 5–10 = 1) in Models 2 and 3. To assess the level of knowledge, an overall knowledge score was constructed giving 1 point for each correct answer to the ten questions about HPV and respondents with a score above the median were considered to have knowledge of HPV infection and of the main preventive measures. Multiple imputation (10 imputed datasets), by assuming that data were missing at random, with chained equations with linear regression for continuous variables and logistic regression for binary variables has been used to fill the missing values. All variables from the logistic regression analysis have been included in the imputation models. To perform multiple imputation analysis, the multilevel mixed-effects logistic regression models have been fitted to the multiple imputed datasets and the results combined using Rubin’s rules. For all analyses, two-sided tests, p-values ≤ 0.05, were considered statistically significant. The results from the multiple imputation analysis have been presented as the primary study results.

3. Results

Of the 1652 randomly selected students, 1612 returned the questionnaire for a response rate of 97.6%. The principal characteristics of the enrolled participants are described in Table 1. The mean age of the participants was 21.9 years, more than half were female and were medical students, almost all were heterosexual, 35% had smoked at least 100 cigarettes during their lifetime, 87.6% consumed alcohol, more than three-quarters have had a sexual intercourse and half of them currently had a regular partner, less than three-quarters often/always used condoms during their sexual activity, 73.3% have had oral sex, and only 5.3% had a family history of HPV-related cancers.
Table 2 reports the answers of the ten questions that were used to assess the respondents’ knowledge about HPV. The vast majority were able to recognize HPV as a sexually transmitted infection (88%), that it interested both sexes (90.2%), and that it is responsible for cervical cancer (78.4%), although the other associated cancers have been identified by a lower number of respondents ranging from 33.2% for the oral to 51% for the penile. The efficacy of the HPV vaccine in preventing cervical cancer was recognized by two-thirds of the sample (66%) and only 7.6% for oral and penile cancers. The majority indicated that condom use helps to prevent the transmission (80%), but only 20% indicated a lower number of sexual partners.
The median value of the knowledge score was 4 (range = 0–10) and less than half of the participants (41.7%) had a score greater than or equal to 5 and were knowledgeable about HPV infection and the main preventive measures. Multilevel mixed-effect logistic regression analysis was used to assess which of the several characteristics influenced the different outcomes of interest and the results for both the complete cases and multiple imputed data are shown in Table 3. The first model was performed to identify factors associated with the level of knowledge about HPV infection and preventive measures. Females (OR = 1.4; 95% CI = 1.06–1.84), those aged 25–30 years (OR = 2.07; 95% CI = 1.47–2.9), those who have had oral sex (OR = 1.52; 95% CI = 1.08-2.15), those who had received information about HPV infection and preventive measures from physicians (OR = 1.77; 95% CI = 1.33–2.35), and those who needed additional information about HPV infection and preventive measures (OR = 1.87; 95% CI = 1.47–2.32) were more likely to be knowledgeable about HPV (Model 1).
A multilevel mixed-effect logistic regression model was performed to identify factors associated with the level of knowledge about HPV among those vaccinated and the results showed that participants aged 25–30 years (OR = 3.12; 95% CI = 1.74–5.39), those who had received information about HPV infection and preventive measures from physicians (OR = 1.52; 95% CI = 1.01–2.26), and those who needed additional information about HPV infection and preventive measures (OR = 1.85; 95% CI = 1.3–2.58) were more likely to be knowledgeable about HPV.
The statements of the perceived risk of acquiring an HPV infection or an HPV-related cancer or a sexually transmitted disease, measured on a 5-point Likert-type scale, indicated that, respectively, 23.9%, 50.7%, and 45.3% were quite/very concerned. The multivariate logistic regression analysis revealed that three factors predicted participant’s perceived risk of HPV. Females (OR = 1.54; 95% CI = 1.13–2.09), those knowledgeable about HPV infection and of the main preventive measures (OR = 1.69; 95% CI = 1.31–2.18), and those who needed additional information about HPV infection and preventive measures (OR = 1.53; 95% CI = 1.19–1.97) were more likely to be quite/very concerned about the risk of acquiring an HPV infection (Model 2 in Table 3). A high level of perceived utility of the vaccine, of the Pap test, and of the DNA HPV test, measured on a 10-point Likert-type scale, has been observed with mean total values of 8.9, 8.8, and 8.4, respectively.
Only 39.1% of the respondents clearly remembered having received at least one HPV vaccination dose, whereas 29.2% and 31.7%, respectively, did not receive it or did not remember whether they had been vaccinated. Multivariate logistic regression analysis identified that females (OR = 2.29; 95% CI = 1.52–3.43), those enrolled in the field of health sciences (OR = 1.66; 95% CI = 1.11–2.48), those who did not report a prior history of a STI (OR = 0.3; 95% CI = 0.11–0.91), and those knowledgeable of HPV infection and of the main preventive measures (OR = 1.52; 95% CI = 1.02–2.26) were more willing to receive the HPV vaccination (Model 3 in Table 3). Regarding the most cited reasons behind why participants were willing to be vaccinated, 70.5% believed that the vaccine could reduce the risk of getting an HPV infection and 59% had high trust in the vaccination, whereas the top reason indicated for being unwilling to be vaccinated was not feeling at risk of infection (63.6%).
More than two-thirds of the sample had received information about HPV infection (67.9%) and related preventive measures (66.9%). Physicians and the Internet were mentioned as the two principal sources of information, with overall values of 22% and 20.3%, respectively. More than half (54.5%) of the students expressed the need to have additional information.

4. Discussion

This is the first detailed survey on the level of knowledge, attitudes, and behaviors towards HPV infection and preventive measures in the post-acute phase of COVID-19 among university students in Italy. Several implications for public health interventions and communication strategies can be drawn from this survey.
First, assessing the level of knowledge identified some major gaps among the sampled students for the different items regarding HPV. Indeed, only one-third and one-half were able to recognize, respectively, that oral and penile cancers were HPV-associated, two-thirds correctly identified the role of the HPV vaccine in preventing cervical cancer, and only 20.1% that a lower number of sexual partners helps to prevent HPV transmission. Given these gaps, improving the level of knowledge is of particular importance because the present survey reported that having a high level of general knowledge about HPV was positively associated with a favorable attitude towards vaccination and a higher likelihood of intention among the unvaccinated respondents who are at a higher risk.
Second, only 39.1% have already received at least one HPV vaccination dose, whereas 29.2% and 31.7% have not been vaccinated or did not remember. This figure is close to that from Switzerland where 36.9% of university students had received at least one HPV vaccination dose [18], whereas a remarkably higher value of 76.4% has been found among individuals aged 18 to 26 years who had received at least two doses in the US [19], and lower values of 21% in medical students in India [20], and 4.3% in undergraduate university students in Turkey [21]. The substantial differences that emerged in the prevalence across the studies could possibly be accounted for by variations in several factors, such as the year of the survey, sampling procedures, socio-demographic backgrounds of the studied population, health-care workers recommendation, difficulty accessing vaccination, parent’s attitudes, and the health-care delivery system. The very unsatisfactory vaccination uptake underscored the urgent need to implement targeted public health strategies and to dispense educational activities to both parents in order to vaccinate their children when they are eligible, and students in order to motivate and to encourage them to receive the HPV vaccine.
Third, the willingness to receive the HPV vaccine among those unvaccinated or who did not remember was very low with a value of 59.4%, whereas 33.9% were uncertain, and 6.7% did not want to be vaccinated. This observed intention was considerably lower than the values of 69.8% among female university students in Kuwait [22], and 65.2% in medical, dental, and nursing students in India [23]; whereas it was considerably higher than the 22.5% in university students in China [24] and the 4.6% in the already mentioned sample in the US [19]. It is worth noting that the low perceived risk of getting the HPV infection was the main reason for being unwilling to be vaccinated. Similar results have been observed in previous surveys among different groups of participants [4,25,26,27,28,29].
Fourth, the other findings of the multivariate logistic regression analysis indicated that several socio-demographic and general characteristics, such as age, gender, university course, sexual behaviors, and health status, were independently identified as significant determinants of the outcomes of interest. Understanding these characteristics is useful for identifying individuals for targeted efforts to increase, for example, the HPV vaccination uptake. This survey adds to the prevailing evidence that respondents aged 25–30 years had a higher level of knowledge. One possible explanation for these associations could be that those that are younger are less exposed to the infection risk and consequently they perceive themselves to be at lower risk while, in contrast, as age increases, the prevalence of the infection and of the associated diseases increases, making those that are older more knowledgeable, with a more positive attitude towards the importance of the vaccination. Moreover, knowledge about HPV infection and preventive measures, concern about acquiring an HPV infection and a related cancer, and willingness to receive the vaccine were observed to be significantly higher in women. In the literature, similar surveys from different countries among different groups of individuals have shown that women generally have a higher knowledge and more positive attitudes towards HPV vaccination than men [28,30,31]. The most reasonable explanations for the differences observed according to gender, are that this vaccination is recommended and offered free of charge to healthy females at the age of 12–25 years and to males only at 12 years, and that health education activities to prevent HPV infection have focused primarily on cervical cancer. Therefore, male students may be less aware of the potential impact of HPV infection on them and on the benefits of the vaccination. However, the low level of knowledge about HPV in men increases the risk of transmission. This finding has been observed in similar surveys conducted worldwide [29,32]. Another interesting observation, in agreement with previous studies from different countries [33,34], was that students enrolled in the field of health sciences are more willing to receive the vaccination compared to those in a non-health-related field. This finding was expected and could be explained by the fact that students in health-related fields receive information on HPV infection, associated cancers, and preventive measures through their courses, compared to those in non-health-related fields. These findings further emphasize the importance of adequate health information that may play an important role in educating students in non-health-related fields. Not surprisingly, students who have had oral sex reported a higher knowledge. This may be because those who are engaged in sexual behaviors with a substantial risk of getting an HPV infection have more interested in the vaccination. In addition, participants who did not report a prior history of an STI were almost 70% more likely to be willing to receive the HPV vaccination than those with a prior STI diagnosis.
Fifth, assessments of the principal sources used to gain information about HPV infection and related preventive measures, revealed that physicians, although only in about a fifth of the respondents, were the most widely used, followed by the internet. The findings regarding the sources of information clearly provide evidence and offer insight that physicians may directly and positively impact respondents’ knowledge and attitudes. Indeed, respondents who received information from physicians had higher HPV infection and preventive measures knowledge and positive health care attitudes. Numerous studies among diverse populations from different geographic areas, have found that healthcare professionals, especially physicians, are the preferred source of health-related information and have emphasized the importance of providing preventive campaigns, which may translate into safer and more appropriate behaviors [35,36]. However, of great concern is that only about a fifth of the respondents had received information from physicians, considering that they are an important source that can positively reflect healthier life habits in the population of university students. Furthermore, most respondents stated the need for more information, and this is a salient theme, particularly because in the multivariate logistic regression analysis, this need was significantly associated with all but one outcome of interest. Thus, more interaction with physicians, mainly those involved in direct and longer interactions with patients and their families, and tailored educational interventions are required to provide accurate information on the risk factors and on the benefits of the preventive measures and to support and to facilitate decision-making processes among this population.

5. Survey Limitations

It is necessary to acknowledge the possibility of some methodological limitations when interpreting the findings. First, the cross-sectional nature of this survey limits the ability to attribute causation to the associations that have been observed between the independent variables and the outcomes of interest. Second, the population sample was selected from two geographic areas in the Southern part of Italy and, therefore, caution is needed in generalizing these findings more broadly to all Italian students. Third, the data were gathered through a self-administered questionnaire and therefore, the recall bias of participants may have influenced the results, for example, on the sexual habits and on immunization status. Fourth, participants might have more positively answered the questions and therefore, for example, due to the sensitive nature of those regarding sexual behaviors, might be subject to social desirability bias. However, keeping the identity of the participants anonymous, we are confident that this limitation was likely to have had little influence on the results.

6. Survey Implications

The results highlight the need to increase students’ knowledge on HPV. This should be attempted with educational interventions, by involving both schools and universities and physicians, and also by taking advantage of other opportunities to access health services such as primary care visits and vaccination centers. Moreover, the HPV vaccination coverage and the willingness to receive it were very low. Therefore, there is ample room for healthcare policymakers and managers to implement appropriate preventive strategies. Efforts should be made to increase vaccination coverage through targeted interventions that provide a more accessible service, increase the trust in the HPV vaccine for parents and young people, and involve healthcare professionals in preventive programs.

7. Conclusions

In conclusion, the present survey underlined that it is needed to develop and to implement comprehensive educational programs and health interventions as essential tools to meet the information needs of this population and that will contribute to enhancing their knowledge, modify their attitudes and improve the HPV vaccine uptake. The findings of this survey are also useful for future investigations focusing on attitudes and behaviors of healthcare professionals towards HPV infection and vaccination given their key role in increasing vaccination coverage.

Author Contributions

G.D.G., A.B., G.L., C.G.A.N. and M.P. participated in the conception and design of the survey, contributed to the data collection; G.D.G., S.A., F.G., F.L., F.N. and C.P.P. contributed to the data collection; G.D.G. and C.P.P. contributed to data analysis and interpretation; I.F.A., the principal investigator, designed the survey, was responsible for the statistical analysis and interpretation, and wrote the article. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported with a grant from the Italian Ministry of University and Research (MUR) PRIN 2017: 20177MKB4H.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Calabria Centre Local Human Research Ethics Committee (protocol number: 110 18 March 2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

The authors would like to kindly thank all participants for their time and contribution to this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. National Cancer Institute. Human Papillomavirus (HPV) Vaccines. Available online: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet (accessed on 24 July 2023).
  2. Italian Ministry of Health. Piano Nazionale Prevenzione Vaccinale (PNPV) 2017–2019. Available online: https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf (accessed on 24 July 2023).
  3. Italian Ministry of Health. Coperture Vaccinali al 31.12.2021 per HPV. Available online: https://www.salute.gov.it/imgs/C_17_tavole_27_1_7_file.pdf (accessed on 24 July 2023).
  4. Di Giuseppe, G.; Abbate, R.; Liguori, G.; Albano, L.; Angelillo, I.F. Human papillomavirus and vaccination: Knowledge, attitudes, and behavioural intention in adolescents and young women in Italy. Br. J. Cancer 2008, 99, 225–229. [Google Scholar] [CrossRef]
  5. Ishimoto, T.; Yagi, A.; Nakajima, K.; Okamoto, N.; Yukimitsu, E.; Kawasaki, M.; Kawae, Y.; Hayasaka, S.; Ueda, Y.; Kimura, T. A questionnaire survey on the prevention of HPV infection among females and males who came of age in Japan under various scenarios of HPV vaccine recommendation. Hum. Vaccines Immunother. 2023, 19, 2229222. [Google Scholar] [CrossRef]
  6. Bianco, A.; Pileggi, C.; Iozzo, F.; Nobile, C.G.; Pavia, M. Vaccination against human papilloma virus infection in male adolescents: Knowledge, attitudes, and acceptability among parents in Italy. Hum. Vaccines Immunother. 2014, 10, 2536–2542. [Google Scholar] [CrossRef]
  7. Yi, Y.; Xiu, S.; Shi, N.; Huang, Y.; Zhang, S.; Wang, Q.; Yang, L.; Cui, T.; Wang, Y.; Shen, Y.; et al. Perceptions and acceptability of HPV vaccination among parents of female adolescents 9–14 in China: A cross-sectional survey based on the theory of planned behavior. Hum. Vaccines Immunother. 2023, 19, 2225994. [Google Scholar] [CrossRef]
  8. Jin, S.W.; Lee, Y.; Brandt, H.M. Human Papillomavirus (HPV) vaccination knowledge, beliefs, and hesitancy associated with stages of parental readiness for adolescent HPV vaccination: Implications for HPV vaccination promotion. Trop. Med. Infect. Dis. 2023, 8, 251. [Google Scholar] [CrossRef] [PubMed]
  9. Mascaro, V.; Pileggi, C.; Currà, A.; Bianco, A.; Pavia, M. HPV vaccination coverage and willingness to be vaccinated among 18–30 year-old students in Italy. Vaccine 2019, 37, 3310–3316. [Google Scholar] [CrossRef] [PubMed]
  10. Dai, Z.; Si, M.; Su, X.; Wang, W.; Zhang, X.; Gu, X.; Ma, L.; Li, J.; Zhang, S.; Ren, Z.; et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J. Med. Virol. 2022, 94, 2776–2786. [Google Scholar] [CrossRef] [PubMed]
  11. Gauna, F.; Verger, P.; Fressard, L.; Jardin, M.; Ward, J.K.; Peretti-Watel, P. Vaccine hesitancy about the HPV vaccine among French young women and their parents: A telephone survey. BMC Public Health 2023, 23, 628. [Google Scholar] [CrossRef]
  12. Napolitano, F.; Navaro, M.; Vezzosi, L.; Santagati, G.; Angelillo, I.F. Primary care pediatricians’ attitudes and practice towards HPV vaccination: A nationwide survey in Italy. PLoS ONE 2018, 13, e0194920. [Google Scholar] [CrossRef]
  13. Napolitano, F.; Pelullo, C.P.; Della Polla, G.; Angelillo, I.F. HPV vaccination attitudes and behaviors among general practitioners in Italy. Vaccines 2021, 9, 63. [Google Scholar] [CrossRef]
  14. Ayres, S.; Gee, A.; Kim, S.; Hashibe, M.; Praag, A.; Kaiser, D.; Chang, C.P.; Brandt, H.M.; Kepka, D. Human Papillomavirus vaccination knowledge, barriers, and recommendations among healthcare provider groups in the Western United States. J. Cancer Educ. 2022, 37, 1816–1823. [Google Scholar] [CrossRef]
  15. SeyedAlinaghi, S.; Karimi, A.; Mojdeganlou, H.; Alilou, S.; Mirghaderi, S.P.; Noori, T.; Shamsabadi, A.; Dadras, O.; Vahedi, F.; Mohammadi, P.; et al. Impact of COVID-19 pandemic on routine vaccination coverage of children and adolescents: A systematic review. Health Sci. Rep. 2022, 5, e00516. [Google Scholar] [CrossRef] [PubMed]
  16. Shet, A.; Carr, K.; Danovaro-Holliday, M.C.; Sodha, S.; Prosperi, C.; Wunderlich, J.; Wonodi, C.; Reynolds, H.; Mirza, I.; Gacic-Dobo, M.; et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: Evidence of disruption and recovery from 170 countries and territories. Lancet Glob. Health 2022, 10, e186–e194. [Google Scholar] [CrossRef]
  17. Walker, B.; Anderson, A.; Stoecker, C.; Shao, Y.; LaVeist, T.A.; Callison, K. COVID-19 and routine childhood and adolescent immunizations: Evidence from Louisiana Medicaid. Vaccine 2022, 40, 837–840. [Google Scholar] [CrossRef]
  18. Jäger, L.; Senn, O.; Rosemann, T.; Plate, A. Assessment of Human Papillomavirus vaccination in primary care among Swiss university students. JAMA Netw. Open 2023, 6, e233949. [Google Scholar] [CrossRef] [PubMed]
  19. Arevalo, M.; Brownstein, N.C.; Whiting, J.; Vadaparampil, S.T.; Head, K.J.; Meade, C.D.; Islam, J.Y.; Kasting, M.L.; Gwede, C.K.; Barrios-Monroy, V.; et al. Factors related to human papillomavirus vaccine uptake and intentions among adults aged 18–26 and 27–45 years in the United States: A cross-sectional study. Cancer 2023, 129, 1237–1252. [Google Scholar] [CrossRef] [PubMed]
  20. Padmanabha, N.; Kini, J.R.; Alwani, A.A.; Sardesai, A. Acceptability of human papillomavirus vaccination among medical students in Mangalore, India. Vaccine 2019, 37, 1174–1181. [Google Scholar] [CrossRef]
  21. Aynaci, G.; Guksu, Z. Awareness of HPV and HPV vaccination in undergraduate students in the North West region of Turkey: Near future outlook. J. Infect. Dev. Ctries. 2019, 13, 516–525. [Google Scholar] [CrossRef]
  22. Alsanafi, M.; Salim, N.A.; Sallam, M. Willingness to get HPV vaccination among female university students in Kuwait and its relation to vaccine conspiracy beliefs. Hum. Vaccines Immunother. 2023, 19, 2194772. [Google Scholar] [CrossRef]
  23. Shetty, S.; Prabhu, S.; Shetty, V.; Shetty, A.K. Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India. Hum. Vaccines Immunother. 2019, 15, 1656–1665. [Google Scholar] [CrossRef]
  24. Ma, Y.; Wang, C.; Liu, F.; Lian, G.; Li, S.; He, Q.; Li, T. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China. Hum. Vaccines Immunother. 2021, 17, 3603–3612. [Google Scholar] [CrossRef] [PubMed]
  25. Pelullo, C.P.; Di Giuseppe, G.; Angelillo, I.F. Human papillomavirus infection: Knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy. PLoS ONE 2012, 7, e42856. [Google Scholar] [CrossRef] [PubMed]
  26. Napolitano, F.; Napolitano, P.; Liguori, G.; Angelillo, I.F. Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy. Hum. Vaccines Immunother. 2016, 12, 1504–1510. [Google Scholar] [CrossRef] [PubMed]
  27. Santhanes, D.; Yong, C.P.; Yap, Y.Y.; Saw, P.S.; Chaiyakunapruk, N.; Khan, T.M. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis. Sci. Rep. 2018, 8, 3640. [Google Scholar] [CrossRef]
  28. Pelullo, C.P.; Esposito, M.R.; Di Giuseppe, G. Human papillomavirus infection and vaccination: Knowledge and attitudes among nursing students in Italy. Int. J. Environ. Res. Public. Health 2019, 16, 1770. [Google Scholar] [CrossRef]
  29. Suzuki, T.; Ota, Y.; Sakata, N.; Fujita, N.; Kamatsuka, M.; Nagashima, K.; Hirayama, J.; Fujita, N.; Shiga, K.; Oyama, N.; et al. HPV vaccine intention among university students during suspension of active recommendation in Japan. Hum. Vaccines Immunother. 2022, 18, 2116900. [Google Scholar] [CrossRef]
  30. Tung, W.C.; Lu, M.; Qiu, X.; Ervin, S. Human papillomavirus knowledge, attitudes, and vaccination among Chinese college students in the United States. Vaccine 2019, 37, 3199–3204. [Google Scholar] [CrossRef] [PubMed]
  31. Varer Akpinar, C.; Alanya Tosun, S. Knowledge and perceptions regarding Human Papillomavirus (HPV) and willingness to receive HPV vaccination among university students in a north-eastern city in Turkey. BMC Womens Health 2023, 23, 299. [Google Scholar] [CrossRef]
  32. Chowdhury, S.; Ara, R.; Roy, S.; Tanvir, S.M.S.; Eva, F.N.; Neela, T.M.; Moonmoon, A.A.; Sifat, S.; Zamila, M.; Hawlader, M.D.H. Knowledge, attitude, and practices regarding human papillomavirus and its’ vaccination among the young medical professionals and students of Bangladesh. Clin. Exp. Vaccine Res. 2022, 11, 63–71. [Google Scholar] [CrossRef]
  33. El Mansouri, N.; Ferrera, L.; Kharbach, A.; Achbani, A.; Kassidi, F.; Rogua, H.; Ait Wahmane, S.; Belmouden, A.; Chouham, S.; Nejmeddine, M. Awareness and knowledge associated to human papillomavirus infection among university students in Morocco: A cross-sectional study. PLoS ONE 2022, 17, e0271222. [Google Scholar] [CrossRef]
  34. Aldawood, E.; Alzamil, L.; Faqih, L.; Dabbagh, D.; Alharbi, S.; Hafiz, T.A.; Alshurafa, H.H.; Altukhais, W.F.; Dabbagh, R. Awareness of Human Papillomavirus among male and female university students in Saudi Arabia. Healthcare 2023, 11, 649. [Google Scholar] [CrossRef] [PubMed]
  35. Wang, K.; Wong, E.L.; Cheung, A.W.; Yau, P.S.; Chung, V.C.; Wong, C.H.; Dong, D.; Wong, S.Y.; Yeoh, E.K. Influence of vaccination characteristics on COVID-19 vaccine acceptance among working-age people in Hong Kong, China: A discrete choice experiment. Front. Public. Health 2021, 9, 793533. [Google Scholar] [CrossRef] [PubMed]
  36. Davis, T.C.; Beyl, R.; Bhuiyan, M.A.N.; Davis, A.B.; Vanchiere, J.A.; Wolf, M.S.; Arnold, C.L. COVID-19 concerns, vaccine acceptance and trusted sources of information among patients cared for in a safety-net health system. Vaccines 2022, 10, 928. [Google Scholar] [CrossRef] [PubMed]
Table 1. Main characteristics and sexual behaviors of the respondents.
Table 1. Main characteristics and sexual behaviors of the respondents.
Total (n = 1612)Having Received the HPV Vaccination
Yes (n = 630)No/Do Not Remember (n = 982)
CharacteristicsN%N%N%
Age21.9 ± 2.4 (18–30) *21.7 ± 2.1 (18–30) *22 ± 2.6 (18–30) *
18–24136886.755740.781159.3
25–3021013.36832.414267.6
Gender
Female97460.438839.858660.2
Male63839.6446.959493.1
Sexual orientation
Heterosexual149993.958138.891861.2
Asexual/bisexual/gay/lesbian/pansexual976.14546.45253.6
Undergraduate course
Medical area85152.842950.442249.6
Other76147.256073.620126.4
Having smoked at least 100 cigarettes during lifetime
No10476563460.541339.5
Yes5653521738.434861.6
Consuming alcohol
No20012.4603014070
Yes141287.657040.484259.6
Having had sexual intercourse during lifetime
No36522.615442.221157.8
Yes124777.447638.277161.8
Current sexual partners
Regular86365.335841.550558.5
Casual145114329.710270.3
None31323.710433.220966.8
Lifetime gender of sexual partners
Opposite112992.442637.770362.3
Same554.522403360
Both383.119501950
Condom use during sexual intercourse
Never/rarely/sometimes46637.419541.827158.2
Often/always78162.62813650064
Having had oral sex during lifetime
No43126.717239.925960.1
Yes118173.345838.872361.2
Condom use during oral sex
Never/rarely/sometimes107791.241938.965861.1
Often/always1048.83937.56562.5
Family history of HPV-related cancers
No77948.328736.849263.2
Other cancers74846.431341.843558.2
Yes855.33035.35564.7
Having received at least one HPV vaccination dose
No47129.2
Do not remember51131.7
Yes63039.1
* Mean ± Standard deviation (range). Number for each item may not add up to total number of study population due to missing values.
Table 2. Knowledge about HPV of the respondents.
Table 2. Knowledge about HPV of the respondents.
Having Received the HPV Vaccination
Total (n = 1612)Yes (n = 630)No/Do Not Remember (n = 982)
N%N%N%
HPV is a sexually transmitted infection
Yes1418885824183659
No194124824.714675.3
HPV infection can affect
Females372.31437.82362.2
Males3321030.32369.7
Females and males145490.258940.586559.5
Do not know885.51719.37180.7
HPV related cancers
Cervical126378.45434372057
Penile8235131838.650561.4
Anal59136.722137.437062.6
Oral53533.223143.230456.8
Preventive measures for HPV infection
Condoms (yes)129280.251039.578260.5
Reducing number of sexual partners (yes)32420.111836.420663.6
Oral disinfectants (no)694.32739.14260.9
Contraceptive (no)623.81625.84674.2
HPV vaccination prevents
Cervical cancer107366.647644.459755.6
Genital cancer59336.818230.741169.3
Anal cancer1227.64536.97763.1
Oral cancer1227.64637.77662.3
A pap-test is an effective screening method for early detection of cervical cancer
Yes12417753743.370456.7
No/Do not know371239325.127874.9
DNA testing for HPV is an effective screening method for early detection of cervical cancer
Yes82751.331337.851462.2
No/Do not know78548.731740.446859.6
Urine test for early detection of genital cancer
Yes60337.423639.136760.9
No/Do not know100962.63943961561
Urine test for early detection of cervical cancer
Yes52537.617633.534966.5
No/Do not know108762.445441.863359.2
Saliva test for early detection of oral cancer
Yes40024.812230.527869.5
No/Do not know121275.250841.970458.1
Table 3. Multilevel mixed-effect logistic regression analysis results examining the outcomes of interest according to several explanatory variables on both the complete cases and multiple imputed data.
Table 3. Multilevel mixed-effect logistic regression analysis results examining the outcomes of interest according to several explanatory variables on both the complete cases and multiple imputed data.
Complete CasesMultiple Imputation
VariableORSE95% CIp ValueORSE95% CIp Value
Model 1. Knowledge of HPV infection and of the main preventive measures
Aged 25–30 years2.120.361.52–2.97<0.0012.070.361.47–2.9<0.001
Needing additional information about HPV infection and preventive measures1.870.221.49–2.35<0.0011.870.211.47–2.32<0.001
Physicians as source of information about HPV infection and preventive measures1.750.261.32–2.33<0.0011.770.261.33–2.35<0.001
Females1.390.191.05–1.830.021.40.191.06–1.840.016
Having had oral sex1.520.271.07–2.160.0181.520.271.08–2.150.017
HPV vaccination status
Yes1 * 1 *
Do not remember0.730.110.54–0.990.050.740.110.54–1.010.051
No1.230.190.91–1.670.1731.240.190.92–1.670.16
Reporting a prior history of a sexually transmitted infection1.670.660.77–3.630.1921.720.680.79–3.730.168
Students enrolled in the field of health sciences1.490.630.65–3.420.3431.540.640.68–3.490.297
Current sexual partners
None1 *
Regular1.080.140.83–1.410.5621.040.140.81–1.350.767
Casual0.740.170.47–1.150.1810.690.150.44–1.070.095
Consuming alcohol1.120.20.78–1.590.5381.070.190.76–1.540.644
Being a smoker1.070.130.84–1.360.5811.080.130.85–1.360.537
Family history of HPV-related cancers
Yes1 *
No0.870.220.53–1.430.5920.880.220.54–1.440.614
Other cancers1.060.270.65–1.750.8041.090.270.66–1.780.742
Having had sexual intercourse during lifetime1.030.20.71–1.510.88
Model 2. Quite/very concerned about the risk of acquiring an HPV infection
Knowledge of HPV infection and of the main preventive measures1.630.211.26–2.11<0.0011.690.221.31–2.18<0.001
Needing additional information about HPV infection and preventive measures1.590.211.21–2.010.0011.530.191.19–1.970.001
Females1.490.231.09–2.030.011.540.241.13–2.090.005
Family history of HPV-related cancers
Yes1 *
No0.590.160.35–1.010.0530.610.160.36–1.020.058
Other cancers0.80.210.48–1.340.3950.810.210.48–1.350.407
Reporting a prior history of a sexually transmitted infection1.850.720.87–3.960.1121.880.730.88–4.040.103
Asexual/bisexual/gay/lesbian/pansexual0.720.170.45–1.160.1820.710.170.45–1.150.164
Physicians as source of information about HPV infection and preventive measures1.190.190.88–1.620.2641.20.190.88–1.630.247
Students enrolled in the field of health sciences1.380.470.71–2.710.3401.40.190.71–2.760.324
Having had oral sex1.070.160.81–1.430.6321.090.160.82–1.450.554
HPV vaccination status
Yes1 *
Do not remember0.890.150.63–1.250.5110.910.160.65–1.280.607
No1.020.170.73–1.420.8991.020.170.74–1.420.896
Aged 25–30 years1.040.190.73–1.510.8171.040.190.72–1.510.820
Model 3. Willingness to receive HPV vaccine
Females2.260.511.45–3.51<0.0012.290.471.52–3.43<0.001
Knowledge of HPV infection and of the main preventive measures1.540.341.01–2.360.0471.520.311.02–2.260.039
Students enrolled in the field of health sciences2.230.911.01–4.980.0491.660.341.11–2.480.013
Not reporting a prior history of a sexually transmitted infection0.370.210.11–1.160.0880.30.170.11–0.910.034
Asexual/bisexual/gay/lesbian/pansexual0.510.240.21–1.310.1640.410.190.16–1.010.052
Physicians as source of information about HPV infection and preventive measures1.240.340.73–2.130.4221.220.310.74–2.010.443
* Reference category.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Di Giuseppe, G.; Angelillo, S.; Bianco, A.; Gallè, F.; Licata, F.; Liguori, G.; Napolitano, F.; Nobile, C.G.A.; Pavia, M.; Pelullo, C.P.; et al. Evaluating Knowledge, Attitudes, and Behaviors toward HPV Infection and Vaccination among University Students in Italy. Vaccines 2023, 11, 1517. https://doi.org/10.3390/vaccines11101517

AMA Style

Di Giuseppe G, Angelillo S, Bianco A, Gallè F, Licata F, Liguori G, Napolitano F, Nobile CGA, Pavia M, Pelullo CP, et al. Evaluating Knowledge, Attitudes, and Behaviors toward HPV Infection and Vaccination among University Students in Italy. Vaccines. 2023; 11(10):1517. https://doi.org/10.3390/vaccines11101517

Chicago/Turabian Style

Di Giuseppe, Gabriella, Silvia Angelillo, Aida Bianco, Francesca Gallè, Francesca Licata, Giorgio Liguori, Francesco Napolitano, Carmelo Giuseppe Angelo Nobile, Maria Pavia, Concetta Paola Pelullo, and et al. 2023. "Evaluating Knowledge, Attitudes, and Behaviors toward HPV Infection and Vaccination among University Students in Italy" Vaccines 11, no. 10: 1517. https://doi.org/10.3390/vaccines11101517

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop